Historical record - last NADAC publication: 1/17/2018
Product Information
CEFIXIME 200 MG/5 ML SUSP is a generic product labeled by Aurobindo Pharma Limited, priced at $5.6934 per ML under NDC 65862075275. Its NADAC has been published 123 times since Apr 20, 2016.
Strength
200 mg/5mL
Manufacturer
Aurobindo Pharma LimitedNDC
65862075275
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Last Updated
1/17/2018
Active Ingredients
CEFIXIMEApproval Type
Generic (ANDA)
FDA Application
ANDA204835On Market Since
4/14/2015
Pharmacological Classes
Price Statistics
The NADAC for CEFIXIME 200 MG/5 ML SUSP has been published 123 times since Apr 20, 2016, and over the history we have for it it has declined 9.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.6934 per ML |
|---|---|
| All-time high | $6.3066 (Aug 10, 2016) |
| All-time low | $5.6934 (Jan 17, 2018) |
| Median price | $6.1240 |
| Average price | $5.9637 |
| Largest weekly change | -7.0% (Jan 17, 2018) |
| Weeks tracked | 123 |
| Tracking since | Apr 20, 2016 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFIXIME 200 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFIXIME 200 MG/5 ML SUSP, manufactured by Aurobindo Pharma Limited, is $5.6934 per ML (NDC 65862075275), effective Jan 16, 2019.
How has the price of CEFIXIME 200 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFIXIME 200 MG/5 ML SUSP has declined 9.7%. It has been tracked across 123 weekly CMS publications since Apr 20, 2016.
What are the highest and lowest recorded NADAC prices for CEFIXIME 200 MG/5 ML SUSP?
Since Apr 20, 2016, the NADAC for CEFIXIME 200 MG/5 ML SUSP has ranged from a low of $5.6934 (Jan 17, 2018) to a high of $6.3066 (Aug 10, 2016), with a median of $6.1240 per ML.
Are there cheaper alternatives to CEFIXIME 200 MG/5 ML SUSP?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, CEFIXIME 200 MG/5 ML SUSP, is $4.0251 per ML — about 29% below CEFIXIME 200 MG/5 ML SUSP.
Who manufactures CEFIXIME 200 MG/5 ML SUSP?
CEFIXIME 200 MG/5 ML SUSP (NDC 65862075275) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification